Evidence map›Paper›PMID 38920431›Full record

ReviewGeriatrics (Basel, Switzerland)2024

Statistical Considerations for the Design and Analysis of Pragmatic Trials in Aging Research.

Ashuin Kammar-García, Liliana Aline Fernández-Urrutia, Jorge Alberto Guevara-Díaz, Javier Mancilla-Galindo

Abstract readReview
In one paragraph

Review in Geriatrics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ashuin Kammar-GarcíaDirección de Investigación, Instituto Nacional de Geriatría, Mexico City 10200, Mexico.ORCID 0000-0002-3875-0945
Liliana Aline Fernández-UrrutiaSt. Luke School of Medicine, Alliant International University, Mexico City 11000, Mexico.ORCID 0009-0001-9252-2636
Jorge Alberto Guevara-DíazFaculty of Medicine, Autonomous University of Sinaloa, Culiacan 80019, Mexico.
Javier Mancilla-GalindoInstitute for Risk Assessment Sciences, Utrecht University, 3584 Utrecht, The Netherlands.ORCID 0000-0002-0718-467X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pragmatic trials aim to assess intervention efficacy in usual patient care settings, contrasting with explanatory trials conducted under controlled conditions. In aging research, pragmatic trials are important designs for obtaining real-world evidence in elderly populations, which are often underrepresented in trials. In this review, we discuss statistical considerations from a frequentist approach for the design and analysis of pragmatic trials. When choosing the dependent variable, it is essential to use an outcome that is highly relevant to usual medical care while also providing sufficient statistical power. Besides traditionally used binary outcomes, ordinal outcomes can provide pragmatic answers with gains in statistical power. Cluster randomization requires careful consideration of sample size calculation and analysis methods, especially regarding missing data and outcome variables. Mixed effects models and generalized estimating equations (GEEs) are recommended for analysis to account for center effects, with tools available for sample size estimation. Multi-arm studies pose challenges in sample size calculation, requiring adjustment for design effects and consideration of multiple comparison correction methods. Secondary analyses are common but require caution due to the risk of reduced statistical power and false-discovery rates. Safety data collection methods should balance pragmatism and data quality. Overall, understanding statistical considerations is crucial for designing rigorous pragmatic trials that evaluate interventions in elderly populations under real-world conditions. In conclusion, this review focuses on various statistical topics of interest to those designing a pragmatic clinical trial, with consideration of aspects of relevance in the aging research field.

Indexed as

agedgerosciencepragmatic clinical trialssample sizesecondary data analysisstatistical analysis

Identifiers

PMID38920431
PMCPMC11203240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.